Validation of the Society for Vascular Surgery's Objective Performance Goals for critical limb ischemia in everyday vascular surgery practice

Journal of Vascular Surgery

Volumn 54, Issue 1, 2011, Pages

  Goodney, Philip P ^a   Schanzer, Andres ^b   Demartino, Randall R ^a   Nolan, Brian W ^a   Hevelone, Nathanael D ^c   Conte, Michael S ^c   Powell, Richard J ^a   Cronenwett, Jack L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BYPASS SURGERY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL LIMB ISHCEMIA; DIALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEG BYPASS; LEG REVASCULARIZATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICAL SOCIETY; OBJECTIVE PERFORMANCE GOAL; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SAPHENOUS VEIN; SOCIETY FOR VASCULAR SURGERY; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME; VALIDATION STUDY; VASCULAR STUDY GROUP OF NEW ENGLAND; VASCULAR SURGERY;

EID: 79959819291     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.11.107     Document Type: Article

References (35)

1. A.T. Hirsch Treatment of peripheral arterial diseaseextending "intervention" to "therapeutic choice." N Engl J Med 354 2006 1944 1947 (Pubitemid 43872697)
2. A.T. Hirsch, Z.J. Haskal, and N.R. Hertzer ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus and Vascular Disease Foundation Circulation 113 2006 e463 e654
3. Society of Vascular Surgery website http://www.vascularweb.org Accessed October 2, 2008
4. The Dartmouth Atlas of Cardiovascular and Thoracic Healthcare 1998 Manning Selvage and Lee
5. J.M. Peacock, H.H. Keo, X. Yu, N. Oldenburg, S. Duval, and T.D. Henry Abstract 5788: The Incidence and Health Economic Burden of Critical Limb Ischemia and Ischemic Amputation in Minnesota: 2005-2007 Circulation 120 2009 S1148
6. A.M. Abou-Zamzam Jr, R.W. Lee, G.L. Moneta, L.M. Taylor Jr, and J.M. Porter Functional outcome after infrainguinal bypass for limb salvage J Vasc Surg 25 1997 287 295 discussion 295-7
7. P.P. Goodney, D.L. Likosky, and J.L. Cronenwett Predicting death, amputation, and graft occlusion after lower extremity bypass using risk modeling techniques 2008 Podium presentation at the Vascular Study Group of Northern New England Biannual Meeting Portland, Maine
8. P.P. Goodney, B.W. Nolan, A. Schanzer, J. Eldrup-Jorgensen, D.J. Bertges, and A.C. Stanley Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England Ann Vasc Surg 24 2010 57 68
9. C.D. Owens, K.J. Ho, S. Kim, A. Schanzer, J. Lin, and E. Matros Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification J Vasc Surg 45 2007 944 952 (Pubitemid 46634932)
10. A. Schanzer, J. Mega, J. Meadows, R.H. Samson, D.F. Bandyk, and M.S. Conte Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data J Vasc Surg 48 2008 1464 1471
11. P.P. Goodney, A.W. Beck, J. Nagle, H.G. Welch, and R.M. Zwolak National trends in lower extremity bypass surgery, endovascular interventions, and major amputations J Vasc Surg 50 2009 54 60
12. D.J. Adam, J.D. Beard, T. Cleveland, J. Bell, A.W. Bradbury, and J.F. Forbes Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934 (Pubitemid 41713982)
13. J. Kedora, S. Hohmann, W. Garrett, C. Munschaur, B. Theune, and D. Gable Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease J Vasc Surg 45 2007 10 16 discussion 16 (Pubitemid 46038657)
14. K. McQuade, D. Gable, S. Hohman, G. Pearl, and B. Theune Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease J Vasc Surg 49 2009 109 115 discussion 116
15. A. Kumar, S.S. Brooks, K. Cavanaugh, and B. Zuckerman FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1474 1476
16. M.S. Conte, P.J. Geraghty, A.W. Bradbury, N.D. Hevelone, S.R. Lipsitz, and G.L. Moneta Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia J Vasc Surg 50 2009 1462 1473 e1-3
17. P.J. Geraghty, J.S. Matsumura, and M.S. Conte Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals J Vasc Surg 50 2009 1459 1461
18. E.P. Brass, R. Anthony, J. Dormandy, W.R. Hiatt, J. Jiao, and A. Nakanishi Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia J Vasc Surg 43 2006 752 759
19. M.S. Conte, D.F. Bandyk, A.W. Clowes, G.L. Moneta, L. Seely, and T.J. Lorenz Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery J Vasc Surg 43 2006 742 751 discussion 751
20. R.J. Powell, P.P. Goodney, F.O. Mendelsohn, E.K. Moen, B.H. Annex HGF-0205 Trial Investigators Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial J Vasc Surg 52 2010 1525 1530
21. M.R. Nehler, E.P. Brass, R. Anthony, J. Dormandy, J. Jiao, and T.O. McNamara Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes J Vasc Surg 45 2007 953 960 discussion 960-1
22. J.L. Cronenwett, D.S. Likosky, M.T. Russell, J. Eldrup-Jorgensen, A.C. Stanley, B.W. Nolan VSGNNE A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE) J Vasc Surg 46 2007 1093 1101 discussion 1101-2
23. P.P. Goodney, D.S. Likosky, J.L. Cronenwett Vascular Study Group of Northern New England Factors associated with stroke or death after carotid endarterectomy in Northern New England J Vasc Surg 48 2008 1139 1145
24. D.E. Wennberg, F.L. Lucas, J.D. Birkmeyer, C.E. Bredenberg, and E.S. Fisher Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics JAMA 279 1998 1278 1281 (Pubitemid 28180780)
25. S.M. Taylor, C.A. Kalbaugh, D.W. Blackhurst, A.L. Cass, E.A. Trent, and E.M. Langan 3rd Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions J Vasc Surg 44 2006 747 755 discussion 755-6
26. J.K. Chang, K.D. Calligaro, S. Ryan, D. Runyan, M.J. Dougherty, and J.J. Stern Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital Ann Vasc Surg 17 2003 91 96 (Pubitemid 36249672)
27. A. Bowling, L. Culliford, D. Smith, G. Rowe, and B.C. Reeves What do patients really want? Patients' preferences for treatment for angina Health Expect 11 2008 137 147 (Pubitemid 351724998)
28. J. Redfern, E. Ellis, T. Briffa, and S.B. Freedman Development and testing of innovative patient resources for the management of coronary heart disease (CHD): a descriptive study BMC Health Serv Res 6 2006 95
29. A. Bakhai, R.A. Hill, Y. Dundar, R. Dickson, and T. Walley Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes Cochrane Database Syst Rev 2005 CD004588
30. S.P. Sedlis, K.B. Ramanathan, D.A. Morrison, G. Sethi, J. Sacks, and W. Henderson Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry) Am J Cardiol 94 2004 118 120 (Pubitemid 38813466)
31. J. Hornberger, D.A. Bloch, M.A. Hlatky, and W. Baumgartner Patient preferences in coronary revascularization Am Heart J 137 1999 1153 1162 (Pubitemid 30040742)
32. R.M. Newman, and L.W. Traverso Cost-effective minimally invasive surgery: what procedures make sense? World J Surg 23 1999 415 421 (Pubitemid 29136133)
33. The Deming Cycle http://wwwihiorg/IHI/Topics/Improvement/ ImprovementMethods/HowToImprove/testingchangeshtm
34. P.P. Goodney, D.S. Likosky, J.L. Cronenwett Vascular Study Group of Northern New England Predicting ambulation status one year after lower extremity bypass J Vasc Surg 49 2009 1431 1439 e1
35. P.P. Goodney, B.W. Nolan, and A. Schanzer Factors associated with death 1 year after lower extremity bypass in Northern New England J Vasc Surg 51 2010 71 78